Challenges to health care for diabetes in Africa

European Journal of Preventive Cardiology

Volumn 10, Issue 2, 2003, Pages 103-110

  Whiting, David R ^a,b   Hayes, Louise ^b,c   Unwin, Nigel C ^b,c  

^a Adult Morbidity and Mortality Project (AMMP)   (Tanzania)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Africa; delivery of health care; diabetes mellitus; health priorities; primary health care; quality of health care

Indexed keywords

AFRICA; DIABETES MELLITUS; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; BLOOD PRESSURE; ECONOMICS; GLUCOSE BLOOD LEVEL; MASS SCREENING; METHODOLOGY; PRIMARY PREVENTION;

ANTIDIABETIC AGENT; INSULIN;

AFRICA; BLOOD GLUCOSE; BLOOD PRESSURE; DELIVERY OF HEALTH CARE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MASS SCREENING; PRIMARY PREVENTION;

EID: 0037396682     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/174182670301000205     Document Type: Article

References (48)

1. World Health Organization. World Health Report 2000. Health Systems: Improving Performance. Technical Report. Geneva: World Health Organization; 2000.
2. Levitt N, Mollentzie W. Diabetes mellitus and impaired glucose tolerance. A review of South African studies. In: Forie J, Steyn K (editors): Chronic diseases of lifestyle in South Africa. Cape-Town: MRC Publications; 1995. pp. 99–126.
3. Tappy L, Bovet P, Shamlaye C. Prevalence of diabetes and obesity in the adult population of the Seychelles. Diabet Med 1991; 8: 448–452.
4. El-Shazly M, Abdel-Fattah M, Zaki A, Bedwani R, Assad S, Tognoni G, et al Health care for diabetic patients in developing countries: A case from Egypt. Public Health 2000; 114: 276–281. This study presents a comprehensive assessment of the quality of diabetes care comparing health-insured and non-health-insured patients. The quality of care in these populations is in stark contrast to that in Africa south of the Sahara.
5. King H, Rewers M. Diabetes is now a third world problem. Bull WHO 1991; 69: 643–648.
6. Levitt NS, Zwarenstein MF, Doepfmer S, Bawa AA, Katzenellenbogen J, Bradshaw D. Public sector primary care of diabetics - a record review of quality of care in Cape Town. S Afr Med J 1996; 86: 1013–1017.
7. Levitt NS, Bradshaw D, Zwarenstein MF, Bawa AA, Maphumolo S. Audit of public sector primary diabetes care in Cape Town, South Africa: High prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabet Med 1997; 14: 1073–1077.
8. Goodman GR, Zwarenstein MF, Robinson II, Levitt NS. Staff knowledge, attitudes and practices in public sector primary care of diabetes in Cape Town. S Afr Med J 1997; 87: 305–309.
9. Beattie A, Kalk WJ, Price M, Rispel L, Broomberg J, Cabral J. The management of diabetes at primary level in South Africa: The results of a facility-based assessment. J R Soc Health 1998; 118: 338–345.
10. Amoah AGB, Owusu SK, Saunders JT, Fang WL, Asare HA, Pastors JG, et al Facilities and resources for diabetes care at regional health facilities in southern Ghana. Diabetes Res Clin Pract 1998; 42: 123–130.
11. Kalk WJ, Veriawa Y, Osler C. A survey of hospital outpatient services for chronic diseases in Gauteng. S Afr Med J 2000; 90: 57–61.
12. Daniels AR, Biesma R, Otten J, Levitt NS, Steyn K, Martell R, et al Ambivalence of primary health care professionals towards the South African guidelines for hypertension and diabetes. S Afr Med J 2000; 90: 1206–1211.
13. Unwin N, Mugusi F, Aspray T, Whiting D, Edwards R, Mbanya J, et al Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: The essential NCD health intervention project. Public Health 1999; 113: 141–146. This project is developing a package (including costs) for the treatment of diabetes at a primary health care level and also methods for the rapid evaluation of health care for diabetes at all levels. The package includes treatment protocols, structured record forms, patient education materials, a staff training package, and an audit system based on review criteria.
14. Daniels AR, Patel M, Biesma R, Otten J, Levitt NS, Steyn K, et al A structured record to implement the national guidelines for diabetes and hypertension care. S Afr Med J 2000; 90: 53–56.
15. World Health Organization. Obesity: Preventing and managing the global epidemic. WHO Technical Report Series 894. Geneva: World Health Organization; 2000.
16. Seidell JC. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr 2000; 83: S5–S8.
17. Alemu S, Watkins VJ, Dodds W, Turowska JB, Watkins PJ. Access to diabetes treatment in northern Ethiopia. Diabet Med 1998; 15: 791–794.
18. Coleman R, Gill G, Wilkinson D. Noncommunicable diseases management in resource-poor settings: A primary care model from rural South Africa. Bull WHO 1998; 76: 633–640. This paper describes the design and implementation of simple protocols for the treatment of diabetes by nurses working at primary care facilities using essential drugs. Treatment was focused on preventing symptomatic hyper- and hypoglycaemia rather than measurement of blood glucose or HbA1c. Using these criteria nurses were able to ‘control’ 82% of patients with type 2 diabetes.
19. Watkins PJ. Delivering care for diabetes in Ethiopia. Trans R Soc Trop Med Hyg 1999; 93: 355–356.
20. Herman W, Ali M, Aubert R, Engelgau M, Kenny S, Gunter A, et al Diabetes mellitus in Egypt: Risk factors and prevalence. Diabet Med 1995; 12: 1126–1131.
21. McLarty DG, Pollitt C, Swai A.B.M. Diabetes in Africa. Diabet Med 1990; 7: 670–684.
22. Aspray TJ, Mugusi F, Rashid S, Whiting D, Edwards R, Alberti KG, et al Rural and urban differences in diabetes prevalence in Tanzania: The role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg 2000; 94: 2000.
23. Setel PW, Unwin N, Alberti K, Hemed Y. Cause-specific adult mortality: Evidence from community-based surveillance - selected sites, Tanzania, 1992–1998. Morbidity and Mortality Weekly Report 2000; 49: 416–419. This paper reports the results of a community-based mortality monitoring system that has been developed to provide information for planning as a substitute for vital registration. The system is integrated into the health system and is being expanded to other parts of the country to improve representativeness. The three areas presented demonstrate the variation in cause-specific mortality that exists within countries.
24. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269–1276. The Global Burden of Disease Study aimed to estimate the burden of morbidity and mortality by region to aid objective debates on health policy. This paper shows, among other findings, that the probability of death from a non-communicable disease was greater in sub-Saharan Africa than in established market economies.
25. Cooper RS, Osotimehin B, Kaufman JS, Forrester T. Disease burden in sub-Saharan Africa: What should we conclude in the absence of data? Lancet 1998; 351: 208–210.
26. Bonita R, de Courten M, Dwyer T, Jamrozik K, Winkelmann R. Surveillance of Risk Factors for Non-communicable Diseases: The WHO Stepwise Approach. Technical report. Geneva: World Health Organization; 2001.
27. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997; 20: 537–544.
28. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350.
29. Vijan S, Stevens D, Hermann W, Funnell M, Standiford C. Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice. J Gen Intern Med 1997; 12: 567–580.
30. Kriska AM, Blair SN, Pereira MA. The potential role of physical activity in the prevention of non-insulin dependent diabetes mellitus: The epidemiological evidence. Exerc Sport Sci Rev 1994; 22: 121–143.
31. Wojtaszewski JF, Hansen BF, Gade J, Kiens B, Markuns JF, Goodyear LJ, et al Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 2000; 49: 325–331.
32. Segal L, Dalton AC, Ricardson J. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promotion International 1998; 13: 197–209.
33. Panford S, Nyaney MO, Amoah SO, Aidoo NG. Using folk media in HIV/AIDS prevention in rural Ghana. Am J Public Health 2001; 91: 1559–1562.
34. Swai A, Lutale J, McLarty D. Diabetes in tropical Africa: A prospective study, 1981–7. I. Characteristics of newly presenting patients in Dar es Salaam, Tanzania, 1981–7. BMJ 1990; 300: 1103–1106.
35. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–853.
36. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
37. Gill GV, Huddle KR. Hypoglycaemic admissions among diabetic patients in Soweto, South Africa. Diabet Med 1993; 10: 181–183.
38. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA 1999; 281: 2005–2012.
39. Wikblad K, Smide B, Bergström A, Wahren L, Mugusi F, Jeppsson J. Immediate assessment of HbA1c under field conditions in Tanzania. Diabetes Res Clin Pract 1998; 40: 123–128.
40. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–712. This study demonstrates the importance of good blood pressure control in the management of diabetes, with improvements in a range of outcomes often exceeding those from tight blood glucose control. Tighter control, however, led to increased weight gain.
41. Dagogo-Jack S. DCCT results and diabetes care in developing countries. Diabetes Care 1995; 18: 416–417.
42. Tooke JE, Thomas S, Viberti GC. Proteinuria in diabetes. J Royal Coll Physicians London 2000; 34: 336–339.
43. Hendry BM, Viberti GC, Hummel S, Bagust A, Piercy J. Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in type 1 diabetic patients. QJM 1997; 90: 277–282.
44. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passaa P, et al Prevention of diabetes renal disease with special references to microalbuminuria. Lancet 1995; 346: 1080–1084.
45. Zouvanis M, Pieterse AC, Seftel HC, Joffe BI. Clinical characteristics and outcome of hyperglycaemic emergencies in Johannesburg Africans. Diabet Med 1997; 14: 603–606.
46. McLarty DG, Kinabo L, Swai AB. Diabetes in tropical Africa: A prospective study, 1981–7. II. Course and prognosis. BMJ 1990; 300: 1107–1110.
47. Mason J, O'Keeffe C, McIntosh A, Hutchinson A, Booth A, Young RJ. A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I: Prevention. Diabet Med 1999; 16: 801–812.
48. Yudkin JS. Insulin for the world#x0027;s poorest countries. Lancet 2000; 355: 919–921.